• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[普拉德-威利综合征。2例生长激素治疗]

[Prader-Willi syndrome. Treatment with growth hormone in 2 cases].

作者信息

Youlton R

机构信息

Unidad de Endocrinología y Genética, Departamento de Pediatría, Clínica Las Condes.

出版信息

Rev Med Chil. 2001 Oct;129(10):1186-90.

PMID:11775347
Abstract

Prader-Willi syndrome (PWS) is a neurogenetic disorder caused by the absence or abnormal inactivation of a critical region of the paternal chromosome 15. Clinical manifestations include marked hypotonia at birth, progressive obesity that starts during the second year of life, stunting, hypogonadism and some dysmorphic features. Some of the symptoms and signs can be explained by growth hormone (GH) deficiency. We report two females aged 12 and 13 years old with PWS. Both were very short and obese, showed blunted GH responses to provocative stimuli and had low plasma levels of Insulin Growth Factor-1 (IGF-1). They have been on GH treatment for more than two years, demonstrating a marked growth acceleration, reduction in their fat mass, improvement of their muscular strength and an increase in their IGF-1 levels.

摘要

普拉德-威利综合征(PWS)是一种神经遗传性疾病,由父源15号染色体关键区域的缺失或异常失活引起。临床表现包括出生时明显的肌张力减退、出生后第二年开始的进行性肥胖、发育迟缓、性腺功能减退以及一些畸形特征。部分症状和体征可由生长激素(GH)缺乏来解释。我们报告了两名分别为12岁和13岁的患有PWS的女性。两人均身材矮小且肥胖,对刺激试验的GH反应迟钝,血浆胰岛素样生长因子-1(IGF-1)水平较低。她们接受GH治疗已超过两年,表现出明显的生长加速、脂肪量减少、肌肉力量改善以及IGF-1水平升高。

相似文献

1
[Prader-Willi syndrome. Treatment with growth hormone in 2 cases].[普拉德-威利综合征。2例生长激素治疗]
Rev Med Chil. 2001 Oct;129(10):1186-90.
2
Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.普拉德-威利综合征的生长激素治疗:批判性评估
J Pediatr Endocrinol Metab. 2004 Sep;17 Suppl 4:1297-306.
3
Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.生长激素随机对照试验:对一大组普拉德-威利综合征患儿人体测量学、身体成分和身体比例的影响
Clin Endocrinol (Oxf). 2008 Sep;69(3):443-51. doi: 10.1111/j.1365-2265.2008.03228.x. Epub 2008 Mar 18.
4
Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.生长激素治疗普拉德-威利综合征两年后对身体成分、脂肪利用、体力和敏捷性以及生长的持续益处。
J Pediatr. 2000 Jul;137(1):42-9. doi: 10.1067/mpd.2000.105369.
5
Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment.儿童普拉德-威利综合征患者在生长激素治疗前后的甲状腺激素水平。
Clin Endocrinol (Oxf). 2007 Sep;67(3):449-56. doi: 10.1111/j.1365-2265.2007.02910.x.
6
The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.生长激素治疗普拉德-威利综合征儿童及青少年的行为影响:一项为期2年的对照研究。
Pediatrics. 2002 Feb;109(2):E35. doi: 10.1542/peds.109.2.e35.
7
Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.生长激素治疗对普拉德-威利综合征成年患者的认知、情感、身体及社会影响。
J Intellect Disabil Res. 2005 Apr;49(Pt 4):245-52. doi: 10.1111/j.1365-2788.2005.00641.x.
8
What is the value of growth hormone therapy in Prader Willi syndrome?生长激素治疗普拉德-威利综合征的价值如何?
Arch Dis Child. 2014 Feb;99(2):166-70. doi: 10.1136/archdischild-2013-303760. Epub 2013 Oct 25.
9
Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.生长激素在成年普拉德-威利综合征患者短期和长期给药期间诱导脂肪分解。
Growth Horm IGF Res. 2005 Dec;15(6):411-5. doi: 10.1016/j.ghir.2005.08.005. Epub 2005 Oct 17.
10
Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).普拉德-威利综合征的生长激素治疗与不良事件:来自KIGS(辉瑞国际生长数据库)的数据。
Clin Endocrinol (Oxf). 2006 Aug;65(2):178-85. doi: 10.1111/j.1365-2265.2006.02570.x.